P. Gillman

发表

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

P. Gillman, 2007, British journal of pharmacology.

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.

P. Gillman, P K Gillman, 2005, British journal of anaesthesia.

CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity

P. Gillman, P Ken Gillman, P. Gillman, 2011, Journal of psychopharmacology.

Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.

P. Gillman, 2010, Headache.

Successful treatment of serotonin syndrome with chlorpromazine

P. Gillman, 1996, The Medical journal of Australia.

Serotonin syndrome treated with chlorpromazine.

P. Gillman, 1997, Journal of clinical psychopharmacology.

More on Mrs Murphy's beans: or "Do us a fava".

P. Gillman, 2010, Journal of clinical psychopharmacology.

Neuroleptic malignant syndrome: Mechanisms, interactions, and causality

P. Gillman, 2010, Movement disorders : official journal of the Movement Disorder Society.

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

P. Gillman, R. Ramsay, C. Dunford, 2007, British journal of pharmacology.

The serotonin syndrome and its treatment

P. Gillman, 1999, Journal of psychopharmacology.

Ecstasy, serotonin syndrome and the treatment of hyperpyrexia.

P. Gillman, 1997, Medical Journal of Australia.

Bupropion, Bayesian Logic and Serotonin Toxicity

P. Gillman, 2010, Journal of Medical Toxicology.

The Nature of Hyperthermia in Neuroleptic Malignant Syndrome and the Use of Bromocriptine

P. Gillman, 2010, Journal of Medical Toxicology.

A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status

P. Gillman, 2006, Human psychopharmacology.

Letter to the EditorMisleading Cases

P. Gillman, 2005 .

Possible serotonin syndrome with moclobemide and pethidine

P. Gillman, 1995, Medical Journal of Australia.

Serotonin syndrome following SSRI mono‐therapy

P. Gillman, S. Hodgens, 1998 .

‘Withdrawal neuroleptic malignant syndrome’: a phantom explanatory cause for a fatality

P. Gillman, 2011, Medicine, science, and the law.

Understanding toxidromes: serotonin toxicity: a commentary on Montanes-Rada et al.

P. Gillman, 2005, Journal of clinical psychopharmacology.

Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine.

P. Gillman, 2004, The Journal of antimicrobial chemotherapy.

Olanzapine-Induced Galactorrhea in a Woman with Psychotic Illness

P. Gillman, R. Jiloha, D. N. Mendhekar, 2004 .

Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline

P. Gillman, 2005, Human psychopharmacology.

‘ Comparative efficacy and acceptability of 21 antidepressant drugs ’ , meta-analysis : critical observations and context

P. Gillman, 2018 .